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Background. In immunoglobulin light chain (AL) amyloidosis, clinical and experimental 
observations converge towards a direct toxic role of the amyloidogenic light chain (aLC) 
precursor [1, 2, 3]. However, the molecular underpinnings of AL amyloidosis remain obscure, 
partly due to the paucity of preclinical models for this disease. Generation of conventional 
transgenic mice with constitutive overexpression of human aLCs is technically hampered by 
the potential toxicity of these proteins, possibly resulting in embryolethality and selection 
against high expressor lines [4]. To overcome these limitations, we have employed the 
Cre/loxP system to generate a conditional transgenic mouse allowing regulated expression of 
an aLC. 
 
Materials and methods. The cDNA encoding a human aLC (λ), termed MAB, was sub-
cloned in the pCAG-CAT-Oligo vector [5]. The resulting expression vector consisted of 
(5’→3’): a ubiquitous promoter (CAG), a reporter g ne-stop cassette (CAT) flanked by two 
equally oriented loxP sites and the aLC (MAB). Transgenic mice obtained by pronuclear 
injection in C57BL/6J fertilized oocytes (termed CAG-CAT-MAB) were crossed with either 
mice expressing a constitutively active cre recombinase under the albumin promoter (Alb-cre) 
[6], or with mice expressing a tamoxifen-inducible cre recombinase under the CAG-promoter 
(CAGGS-cre
TM
) [7]. Expression of human aLCs was analyzed by RT-PCR, 
immunohistochemistry, Western blotting and ELISA.  
 
Results. Pronuclear injection of the CAG-CAT-MAB vector resulted in the generation of 
three transgenic lines. CAG-CAT-MAB
Tg/+ 
mice showed ubiquitous expression of the CAT 
reporter gene, but no expression of aLC, as expected. Crossing with Alb-cre transgenic mice 
resulted in hepatocyte-restricted expression of aLC, whereas crossing with CAGGS-cre
 TM
 
transgenic mice lead to ubiquitous expression of aLC after tamoxifen administration (Figure 
1). Human aLC could be detected in serum, and mice with ubiquitous expression show higher 
levels than mice with hepatocyte-restricted expression. Mice with hepatocyte-restricted 
expression of aLC have been monitored for up to two years, with no evidence of amyloid 
formation.  
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Figure 1. Regulated expression of amyloidogenic immunoglobulin light chains in mice.  
Immunohistochemical analysis of human λ expression (in red). Scale bar: 100 µm. 
 
Discussion and conclusions. We have generated a novel transgenic mouse in which the 
expression of aLC can be activated in a spatially and temporally regulated manner. In mice 
with hepatocyte-restricted expression of aLC, all target organs (except the liver) are exposed 
to aLC exclusively coming from the circulation, resembling the clinical situation. Ubiquitous 
expression of aLC results in higher levels of circulating aLC. Additional cre transgenic lines 
can be used to further manipulate the temporal and spatial pattern of aLC expression. This 
newly developed conditional transgenic mouse could prove instrumental to deepen our current 
mechanistic understanding of AL amyloidosis.  
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